XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease June 30, 2022
Published Health Economics Study shows Improved Treatment for Female Urinary Incontinence may have Positive Effect on Patient Outcomes and Healthcare Costs June 22, 2022
Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline June 21, 2022
